| Literature DB >> 34629717 |
Nikitha Murali1, Samdeep K Mouli1, Ahsun Riaz1, Robert J Lewandowski1, Riad Salem1.
Abstract
While initially described and now accepted as treatment for primary and secondary malignancies in the liver, radioembolization therapy has expanded to include treatment for other disease pathologies and other organ systems. Advantages and limitations for these treatments exist and must be compared against more traditional treatments for these processes. This article provides an overview of the current applications for radioembolization outside of the liver, for both malignant and nonmalignant disease. Thieme. All rights reserved.Entities:
Keywords: extrahepatic; interventional radiology; radioembolization; radiotherapy; yttrium-90
Year: 2021 PMID: 34629717 PMCID: PMC8497088 DOI: 10.1055/s-0041-1735573
Source DB: PubMed Journal: Semin Intervent Radiol ISSN: 0739-9529 Impact factor: 1.780